Literature DB >> 6328558

Species differences in the relative analgesic potencies of some classical opiates and opioid peptides.

J I Székely, E Miglécz, S Bajusz.   

Abstract

The analgesic ED50 values of some classical morphine congeners (morphine, methadone, fentanyl, azidomorphine) in the rat and mouse tail-flick tests were found to be similar. However, several synthetic derivatives of the natural enkephalins were more potent in mice than in rats. (These analogs contain D-amino acid in position 2 and D- or L-sulfonic (or phosphonic) acid residue in position 5). beta-Endorphin, D-Met2, Pro5-enkephalinamide and two partial agonists showed intermediate interspecies relative potencies. According to the data obtained, similar opiate receptors might mediate the analgesic action of classical opiates in rats and in mice. However, the opiate receptors responsible for the antinociceptive effects of the above mentioned enkephalin analogues must be dissimilar in the two species examined. The results are discussed in terms of the role of mu- and delta-receptors in mediation of the analgesic effect induced by different types of opioids.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6328558     DOI: 10.1007/bf00427694

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  16 in total

1.  The effects of morphine- and nalorphine- like drugs in the nondependent and morphine-dependent chronic spinal dog.

Authors:  W R Martin; C G Eades; J A Thompson; R E Huppler; P E Gilbert
Journal:  J Pharmacol Exp Ther       Date:  1976-06       Impact factor: 4.030

2.  Opiates and enkephalins: a common binding site mediates their analgesic actions in rats.

Authors:  A Z Zhang; G W Pasternak
Journal:  Life Sci       Date:  1981-08-24       Impact factor: 5.037

3.  Multiple opiate receptors: differential binding of mu, kappa and delta agonists.

Authors:  P L Wood; S E Charleson; D Lane; R L Hudgin
Journal:  Neuropharmacology       Date:  1981-12       Impact factor: 5.250

Review 4.  Multiple opiate receptors in peripheral tissue preparations.

Authors:  M Wüster; R Schulz; A Herz
Journal:  Biochem Pharmacol       Date:  1981-07-15       Impact factor: 5.858

5.  Discriminative stimulus effects of prototype opiate receptor agonists in monkeys.

Authors:  J J Teal; S G Holtzman
Journal:  Eur J Pharmacol       Date:  1980-11-07       Impact factor: 4.432

6.  Enkephalin analogs containing amino sulfonic acid and amino phosphonic acid residues at position 5.

Authors:  S Bajusz; A Z Rónai; J I Székely; A Turán; A Juhász; A Patthy; E Miglécz; I Berzétei
Journal:  FEBS Lett       Date:  1980-08-11       Impact factor: 4.124

7.  Further evaluation of the discriminative effects of morphine in the rat.

Authors:  H E Shannon; S G Holtzman
Journal:  J Pharmacol Exp Ther       Date:  1977-04       Impact factor: 4.030

8.  Endogenous opioid peptides: multiple agonists and receptors.

Authors:  J A Lord; A A Waterfield; J Hughes; H W Kosterlitz
Journal:  Nature       Date:  1977-06-09       Impact factor: 49.962

9.  In vivo antagonism by naloxone of morphine, beta-endorphin and a synthetic enkephalin analog.

Authors:  J I Székely; Z Dunai-Kovács; E Miglécz; A Z Rónai; S Bajusz
Journal:  J Pharmacol Exp Ther       Date:  1978-12       Impact factor: 4.030

10.  Enkephalin-like character and analgesia.

Authors:  A Z Rónai; I P Berzétei; J I Székely; E Miglécz; J Kurgyis; S Bajusz
Journal:  Eur J Pharmacol       Date:  1981-01-29       Impact factor: 4.432

View more
  2 in total

1.  Opioid microinjection into raphe magnus modulates cardiorespiratory function in mice and rats.

Authors:  Kevin M Hellman; Scott J Mendelson; Marco A Mendez-Duarte; James L Russell; Peggy Mason
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-08-26       Impact factor: 3.619

2.  Activity of murine raphe magnus cells predicts tachypnea and on-going nociceptive responsiveness.

Authors:  Kevin M Hellman; Thaddeus S Brink; Peggy Mason
Journal:  J Neurophysiol       Date:  2007-10-03       Impact factor: 2.714

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.